Literature DB >> 1707275

Activation of CD16+ effector cells by rheumatoid factor complex. Role of natural killer cells in rheumatoid arthritis.

C Hendrich1, J G Kuipers, W Kolanus, M Hammer, R E Schmidt.   

Abstract

The role of natural killer (NK) cells in rheumatoid arthritis (RA) remains unclear. A pathogenetic function of rheumatoid factors (RF) also has not been defined. In the present studies, natural killer (NK) cells were examined as a model for FC gamma receptor type III-positive (FC gamma RIII+) cells, with regard to their interaction with RF. NK cell antigen CD16 (FC gamma RIII) and CD56 expression and functional NK and antibody-dependent cell-mediated cytotoxicity (ADCC) activity were compared in peripheral blood lymphocytes and autologous synovial fluid lymphocytes (SFL) of RA patients. Peripheral blood lymphocytes and SFL showed normal CD56 expression. In contrast, both the frequency and the density of CD16 antigen were decreased in SFL. Furthermore, diminished NK cytotoxicity and a significant decrease in ADCC were observed in SF NK cells. In subsequent in vitro studies with normal fresh NK cells, it was demonstrated that IgG-containing RF complexes from RA patients induced a modulation of FC gamma RIII structure from the NK cell surface, a decrease in NK activity, and a complete loss of ADCC. When purified RF was incubated with NK-enriched cell lines from RA patients, increased transcription and subsequent production of interferon-gamma and tumor necrosis factor alpha were observed. These data suggest a direct involvement of RF complexes in the pathogenetic process of chronic inflammation in RA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1707275     DOI: 10.1002/art.1780340407

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  12 in total

1.  Preliminary study on the immunologic background of good clinical outcome in rheumatoid arthritis patients after one month therapy with leflunomide.

Authors:  Gina Manda; Monica Neagu; Carolina Constantin; Ionela Neagoe; Catalin Codreanu
Journal:  Rheumatol Int       Date:  2008-12-19       Impact factor: 2.631

2.  Defect of a complement receptor 3 epitope in a patient with systemic lupus erythematosus.

Authors:  T Witte; F L Dumoulin; J E Gessner; J Schubert; O Götze; C Neumann; R F Todd; H Deicher; R E Schmidt
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

3.  Decreased expression of FcgammaRIII (CD16) by gammadelta T cells in patients with rheumatoid arthritis.

Authors:  M D Bodman-Smith; A Anand; V Durand; P Y Youinou; P M Lydyard
Journal:  Immunology       Date:  2000-04       Impact factor: 7.397

4.  Loss of SH3 domain-binding protein 2 function suppresses bone destruction in tumor necrosis factor-driven and collagen-induced arthritis in mice.

Authors:  Tomoyuki Mukai; Richard Gallant; Shu Ishida; Mizuho Kittaka; Teruhito Yoshitaka; David A Fox; Yoshitaka Morita; Keiichiro Nishida; Robert Rottapel; Yasuyoshi Ueki
Journal:  Arthritis Rheumatol       Date:  2015-03       Impact factor: 10.995

5.  TCR1+ large granular lymphocyte proliferation in rheumatoid arthritis.

Authors:  J G Kuipers; R Jacobs; A Kemper; H Zeidler; R E Schmidt
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

6.  Measurement of soluble Fcgamma receptor type IIIa derived from macrophages in plasma: increase in patients with rheumatoid arthritis.

Authors:  M Masuda; T Morimoto; S Kobatake; N Nishimura; K Nakamoto; X H Dong; Y Komiyama; R Ogawa; H Takahashi
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

7.  Raised granzyme B levels are associated with erosions in patients with early rheumatoid factor positive rheumatoid arthritis.

Authors:  R Goldbach-Mansky; S Suson; R Wesley; C E Hack; H S El-Gabalawy; P P Tak
Journal:  Ann Rheum Dis       Date:  2004-10-07       Impact factor: 19.103

8.  Association of rheumatoid factor production with FcgammaRIIIa polymorphism in Taiwanese rheumatoid arthritis.

Authors:  J-Y Chen; C-M Wang; J-M Wu; H-H Ho; S-F Luo
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

9.  Soluble FcgammaRIIa inhibits rheumatoid factor binding to immune complexes.

Authors:  Bruce D Wines; Amanda Gavin; Maree S Powell; Michael Steinitz; Russell R C Buchanan; P Mark Hogarth
Journal:  Immunology       Date:  2003-06       Impact factor: 7.397

10.  Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion.

Authors:  Cristina Teixeira de Matos; Louise Berg; Jakob Michaëlsson; Li Felländer-Tsai; Klas Kärre; Kalle Söderström
Journal:  Immunology       Date:  2007-05-22       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.